Information for this article came from the Digitial Jounal. The orginal article can be accessed here.
A new malaria drug with the potential to cure the disease and block its transmission, developed by an international group of researchers has progressed to an advanced trial stage.
The new drug, ELQ-300, has been shown to be extremely potent in mice. It belongs to a family of synthetic compounds known as quinolones.